Anebulo Pharmaceuticals Inc (NASDAQ: ANEB) — Healthcare · Share Price, Chart & Market Data
About: Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The company's lead product candidate is the selonabant, a small-molecule antagonist of cannabinoid binding receptor type-1(CB1), which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Lakeway, Texas.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.44 (+0.16%)
ANEBAnebulo Pharmaceuticals Inc
Loading watchlist status…
Trade ANEB now
Anebulo Pharmaceuticals Inc share price
ANEB price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 7:27 am GMT+0
ANEB price performance
-12%
5D
-56.436%
1M
-61.062%
YTD
-59.259%
1Y
ANEB price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 7:27 am GMT+0
ANEB details
ANEB Market Signals